Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 08-2014 | 09-2013 | 08-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,843 | 0 | -8,440 | N/A | -14,496 |
| Depreciation Amortization | 160 | 0 | 158 | 120 | 125 |
| Accounts receivable | -114 | 0 | 121 | N/A | -192 |
| Other Working Capital | -518 | 0 | 208 | -420 | -355 |
| Other Operating Activity | -1,097 | 0 | 3,685 | 12,260 | 12,122 |
| Operating Cash Flow | $-4,412 | $0 | $-4,267 | $11,960 | $-2,796 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 397 | 0 | -5,469 | N/A | N/A |
| PPE Investments | -275 | 0 | -277 | -10 | -10 |
| Investing Cash Flow | $123 | $0 | $-5,746 | $-10 | $-10 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 107 | 0 | 10,788 | N/A | 9,729 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 2 |
| Financing Cash Flow | $107 | $0 | $10,788 | $N/A | $9,731 |
| Exchange Rate Effect | -630 | 0 | -212 | N/A | -65 |
| Beginning Cash Position | 8,769 | 0 | 7,860 | N/A | 999 |
| End Cash Position | 3,956 | 0 | 8,423 | N/A | 7,860 |
| Net Cash Flow | $-4,813 | $0 | $563 | $11,950 | $6,861 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,412 | 0 | -4,267 | 11,960 | -2,796 |
| Capital Expenditure | -275 | 0 | -279 | N/A | -10 |
| Free Cash Flow | -4,687 | 0 | -4,546 | 11,960 | -2,805 |